Back to Search Start Over

A multivariate analysis of the relationship between response and survival among patients with higher-risk myelodysplastic syndromes treated within azacitidine or conventional care regimens in the randomized AZA-001 trial

Authors :
Steven D. Gore
Pierre Fenaux
Valeria Santini
John M. Bennett
Lewis R. Silverman
John F. Seymour
Eva Hellström-Lindberg
Arlene S. Swern
Charles. L. Beach
Alan. F. List
Source :
Haematologica, Vol 98, Iss 7 (2013)
Publication Year :
2013
Publisher :
Ferrata Storti Foundation, 2013.

Abstract

The phase III AZA-001 study established that azacitidine significantly improves overall survival compared with conventional care regimens (hazard ratio 0.58 [95% confidence interval 0.43–0.77], P

Details

Language :
English
ISSN :
03906078, 15928721, and 75041979
Volume :
98
Issue :
7
Database :
Directory of Open Access Journals
Journal :
Haematologica
Publication Type :
Academic Journal
Accession number :
edsdoj.6508cf69c75041979b3ba8331d78d2f5
Document Type :
article
Full Text :
https://doi.org/10.3324/haematol.2012.074831